颅内硬脑膜动静脉瘘的血管内治疗:经静脉途径综述
本文是颅内硬脑膜动静脉瘘血管内治疗系列综述的第三篇,聚焦经静脉栓塞途径。经静脉栓塞已成为海绵窦区和舌下神经管区腹侧硬脑膜动静脉瘘的一线方法,也越来越多用于岩骨区和筛骨区等高危侧方硬膜外瘘。该途径可逆行栓塞引流静脉和瘘口,降低经动脉途径常见的缺血性颅神经病或脑实质梗死风险,腹侧病变血管造影治愈率达80%-90%。
要点
- 腹侧硬脑膜动静脉瘘(海绵窦区、舌下神经管区)首选经静脉栓塞。
- 经静脉途径可降低缺血性颅神经病和脑实质梗死风险。
- 岩骨区、筛骨区等高危侧方硬膜外瘘可考虑经静脉栓塞。
核心结论
- 经静脉栓塞是腹侧硬脑膜动静脉瘘的一线治疗,腹侧病变血管造影治愈率为80%-90%。
- 当硬脑膜动静脉瘘邻近神经滋养血管或颅内外吻合时,应考虑经静脉栓塞。
研究设计与样本
- 本文为针对颅内硬脑膜动静脉瘘血管内治疗的第三篇综述,讨论经静脉栓塞途径,未报告系统检索范围与纳入文献数量。
诊断标准与关键数值
- 经静脉栓塞采用弹簧圈联合或不联合乙烯-乙烯醇共聚物,腹侧病变血管造影治愈率为80%-90%。
临床应用与阅片要点
- 经静脉栓塞可逆行栓塞引流静脉和瘘口,降低经动脉途径常见的缺血性颅神经病或脑实质梗死风险。
- 经静脉栓塞适用于海绵窦区和舌下神经管区的腹侧硬脑膜动静脉瘘。
- 岩骨区和筛骨区等高危侧方硬膜外硬脑膜动静脉瘘可考虑经静脉栓塞。
- 硬脑膜动静脉瘘邻近神经滋养血管或颅内外吻合时,应考虑经静脉栓塞。
局限性
- 经静脉栓塞的潜在并发症包括短暂性颅神经病、静脉流出梗阻导致的神经功能恶化和软脑膜静脉导航时穿孔。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In this third review article on the endovascular management of intracranial dural AVFs, we discuss transvenous embolization approaches. Transvenous embolization is increasingly popular and now the first-line approach for ventral dural AVFs involving the cavernous sinus and hypoglossal canal. In addition, transvenous embolization is increasingly used in lateral epidural dural AVFs in high-risk locations such as the petrous and ethmoid regions. The advantage of transvenous embolization in these locations is the ability to retrogradely embolize the draining vein and fistula while reducing the risk of ischemic cranial neuropathy or brain parenchymal infarction commonly feared from a transarterial approach. By means of coils ± ethylene-vinyl alcohol copolymer, transvenous embolization can achieve angiographic cure rates of 80%-90% in ventral locations. Potential complications include transient cranial neuropathy, neurologic deterioration due to venous outflow obstruction, and perforation while navigating pial veins. Transvenous embolization should be considered when dural AVFs arise in proximity to the vasa nervosum or extracranial-intracranial anastomoses.
引用
- Bhatia KD, Lee H, Kortman H, et al. Endovascular Management of Intracranial Dural AVFs: Transvenous Approach. AJNR Am J Neuroradiol. 2021. PMID: 34649915. doi:10.3174/ajnr.A7300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。